Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-25
Closed -$178 3821
2024
Q2
$178 Sell
25
-75
-75% -$513 ﹤0.01% 3657
2024
Q1
$807 Hold
100
﹤0.01% 3532
2023
Q4
$683 Hold
100
﹤0.01% 3509
2023
Q3
$500 Hold
100
﹤0.01% 3253
2023
Q2
$913 Hold
100
﹤0.01% 3258
2023
Q1
$945 Hold
100
﹤0.01% 3164
2022
Q4
$1 Buy
+100
New +$1.11K ﹤0.01% 3982

Other funds holding AXGN

NewEdge Advisors's AXGN Position: Q3 2024 in Review

NewEdge Advisors sold out of Axogen (AXGN) in Q3 2024, closing a stake of 25 shares — an estimated $178 sold.

NewEdge Advisors first reported a position in AXGN in Q4 2022 and held it in 7 quarters. The position peaked at $945 in Q1 2023. 158 funds tracked by Wall St. Rank hold AXGN as of Q3 2024.

  • NewEdge Advisors reported no remaining Axogen position as of Q3 2024 after selling out during the quarter.
  • NewEdge Advisors sold 25 Axogen shares in Q3 2024, an estimated $178.
  • NewEdge Advisors first reported a position in Axogen in Q4 2022 and held it in 7 quarters.
  • NewEdge Advisors's Axogen position peaked at $945 in Q1 2023.
  • 158 funds tracked by Wall St. Rank held Axogen as of Q3 2024.

Based on NewEdge Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.